Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4137/BIC.S30347 http://scihub22266oqcxt.onion/10.4137/BIC.S30347 C4592056!4592056!26462252     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biomark+Cancer 2015 ; 7 (ä): 51-6 Nephropedia Template TP {{tp|p=26462252|t=2015. Microparticles as Biomarkers of Blood Coagulation in Cancer |pdf=|usr=}}{{26462252}} gab.com Text Microparticles as Biomarkers of Blood Coagulation in Cancer JO: Biomark Cancer http://www.kidney.de/pget.php?&tw=1&pmid=26462252 #FOAvip Cancer is associated with hypercoagulopathy and increased risk of thrombosis. This negatively influences patient morbidity and mortality. Cancer is also frequently complicated by the development of venous thromboembolism (VTE). Tumor-derived tissue factor (TF)-bearing microparticles (MPs) are associated with VTE events in malignancy. MPs are small membrane vesicles released from many different cell types by exocytic budding of the plasma membrane in response to cellular activation or apoptosis. MPs may also be involved in clinical diseases through expression of procoagulative phospholipids. The detection of TF-expressing MPs in cancer patients may be clinically useful. In lung and breast cancer patients, MPs induce metastasis and angiogenesis and may be indicators of vascular complications. Additionally, MPs in patients with various types of cancer possess adhesion proteins and bind target cells to promoting cancer progression or metastasis. Overexpression of TF by cancer cells is closely associated with tumor progression, and shedding of TF-expressing MPs by cancer cells correlates with the genetic status of cancer. Consequently, TF-expressing MPs represent important markers to consider in the prevention of and therapy for VTE complications in cancer patients. Twit Text FOAVip Microparticles as Biomarkers of Blood Coagulation in Cancer ????Biomark Cancer http://www.kidney.de/pget.php?&tw=1&pmid=26462252 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26462252 #FOAvip English Wikipedia <ref>{{Cite pmid|26462252}}</ref> Microparticles as Biomarkers of Blood Coagulation in Cancer #MMPMID26462252 Nomura S; Niki M; Nisizawa T; Tamaki T; Shimizu M Biomark Cancer 2015[]; 7 (ä): 51-6 PMID26462252show ga Cancer is associated with hypercoagulopathy and increased risk of thrombosis. This negatively influences patient morbidity and mortality. Cancer is also frequently complicated by the development of venous thromboembolism (VTE). Tumor-derived tissue factor (TF)-bearing microparticles (MPs) are associated with VTE events in malignancy. MPs are small membrane vesicles released from many different cell types by exocytic budding of the plasma membrane in response to cellular activation or apoptosis. MPs may also be involved in clinical diseases through expression of procoagulative phospholipids. The detection of TF-expressing MPs in cancer patients may be clinically useful. In lung and breast cancer patients, MPs induce metastasis and angiogenesis and may be indicators of vascular complications. Additionally, MPs in patients with various types of cancer possess adhesion proteins and bind target cells to promoting cancer progression or metastasis. Overexpression of TF by cancer cells is closely associated with tumor progression, and shedding of TF-expressing MPs by cancer cells correlates with the genetic status of cancer. Consequently, TF-expressing MPs represent important markers to consider in the prevention of and therapy for VTE complications in cancer patients. äMicroparticles as Biomarkers of Blood Coagulation in Cancer (epmc).pdf DeepDyve Pubget Overpricing